This was the stock's second consecutive day of losses.

Fintel reports that on March 11, 2025, Goldman Sachs upgraded their outlook for GE HealthCare Technologies (NasdaqGS:GEHC) ...

Using Nvidia and GE Healthcare technology, the robotic surgery system is intended to help surgeons diagnose lung cancer ...

Learn more about whether GE HealthCare Technologies Inc. or IDEXX Laboratories, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $104.0, a high estimate of $110.00, and a low estimate of $100.00. Observing a 9.76 ...

Goldman Sachs upgraded GE HealthCare (GEHC) to Buy from Neutral with a price target of $100, up from $85. The firm’s confidence in the outlook ...

Goldman Sachs upgrades GE Healthcare to Buy, raising its price target to $100, as analysts see market stabilization and China ...

Siemens unveiled the two photon-counting CTs in December. GE HealthCare and Philips Healthcare are developing their own ...

Johnson & Johnson MedTech said Wednesday its Monarch Quest robotic platform received clearance from the Food and Drug ...

With half a dozen years of experience, this may be a good time for the healthcare industry to revisit the question in a ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Shares of GE HealthCare Technologies Inc. GEHC slipped 2.10% to $83.79 Wednesday, on what proved to be an all-around mixed ...